載入...

Recurrent Bilateral Strokes in a Patient Treated With Sipuleucel-T for Prostate Cancer

Sipuleucel-T is approved by the US Food and Drug Administration (FDA) for the treatment of castration-resistant prostate cancer (CRPC). Herein, we present a patient with recurrent bilateral embolic stroke who was on sipuleucel-T therapy for CRPC. Laboratory and imaging data didn’t reveal any source...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cureus
Main Authors: Gill, Jashan, Jeelani, Hafiz Muhammad, Prasad, Sonika, Tahir, Nayha
格式: Artigo
語言:Inglês
出版: Cureus 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137308/
https://ncbi.nlm.nih.gov/pubmed/34036014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14596
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!